Stoke Therapeutics (STOK) Other Non-Current Assets (2022 - 2025)
Historic Other Non-Current Assets for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to $721000.0.
- Stoke Therapeutics' Other Non-Current Assets rose 4595.14% to $721000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $721000.0, marking a year-over-year increase of 4595.14%. This contributed to the annual value of $721000.0 for FY2024, which is 2671.35% up from last year.
- As of Q3 2025, Stoke Therapeutics' Other Non-Current Assets stood at $721000.0, which was up 4595.14% from $721000.0 recorded in Q2 2025.
- Stoke Therapeutics' Other Non-Current Assets' 5-year high stood at $721000.0 during Q4 2024, with a 5-year trough of $494000.0 in Q2 2024.
- In the last 4 years, Stoke Therapeutics' Other Non-Current Assets had a median value of $569000.0 in 2022 and averaged $599533.3.
- Per our database at Business Quant, Stoke Therapeutics' Other Non-Current Assets tumbled by 1318.1% in 2024 and then surged by 4595.14% in 2025.
- Quarter analysis of 4 years shows Stoke Therapeutics' Other Non-Current Assets stood at $569000.0 in 2022, then changed by 0.0% to $569000.0 in 2023, then grew by 26.71% to $721000.0 in 2024, then changed by 0.0% to $721000.0 in 2025.
- Its last three reported values are $721000.0 in Q3 2025, $721000.0 for Q2 2025, and $721000.0 during Q1 2025.